context respiratory disease chronic obstruct pulmonary copy lead caps mortal worldwide despite much develop area drug current effect medicine avail treatment ideal proteam antiproteas ratio lung remain import aspect pathophysiolog sever studi shown efficacy therapy vitro vivo model howe indepth require valid lead molecule target proteam review discus current status proteasedirect drug use treat explore future prospect until potent antiproteasebas therapeutic 